CSO and co-founder of @ArsenalBio via @DanaFarber, @broadinstitute, and @Merck. He/his.
Joined October 2009
- Tweets 1,295
- Following 1,130
- Followers 3,195
- Likes 2,079
109 Photos and videos
4 Sep 2024
I’m lucky that I get to work with this team.
4 Sep 2024
We are excited to announce our $325 million #SeriesC financing. This new investment will enable ArsenalBio's ongoing development efforts and scale our manufacturing capabilities to develop T-cell medicines. We thank the new investors along with our existing investors for their support in helping us to achieve our goal to defeat cancer. #celltherapy #patientsfirst
arsenalbio.com/2024/09/04/ar…
1
1
32
5,033
Nick Haining retweeted
14 Apr 2023
Proud to be one of said Braniacs! Looking forward to discussing our exciting work at #AACR2023
14 Apr 2023
There’s some really awesome science going on at @ArsenalBio — come and meet the brainiacs building tomorrow’s cell therapy today at #AACR23 businesswire.com/news/home/2…
2
2
12
3,297
14 Apr 2023
There’s some really awesome science going on at @ArsenalBio — come and meet the brainiacs building tomorrow’s cell therapy today at #AACR23 businesswire.com/news/home/2…
1
7
35
16,233
31 Mar 2023
Well deserved award to a thoughtful and original scientist who has helped us all understand a lot about how T cells work and don’t work. Congrats @EJohnWherry !
We congratulate @EJohnWherry, of @PennMedicine on being recognized with the 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology. Learn more: bit.ly/40qAhnB @CancerResearch
28
5,162
18 Jan 2023
I’m so glad this experiment ended and was reported in my lifetime. Amazing.
18 Jan 2023
Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimulation for over 10yrs! And produce enough progeny to occupy a volume 30,000x the Earth's volume! @Nature nature.com/articles/s41586-0…
3
4
85
27,701
Nick Haining retweeted
18 Jan 2023
Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimulation for over 10yrs! And produce enough progeny to occupy a volume 30,000x the Earth's volume! @Nature nature.com/articles/s41586-0…
35
382
1,370
545,268
5 Jan 2023
Four years ago, the founders had a bunch of ideas on a whiteboard and not much else. Today, @ArsenalBio has dosed the first patient with AB-1015, an engineered autologous T cell therapy for ovarian cancer. Incredibly proud of what the Arsenal team has accomplished. Onwards.
5 Jan 2023
The first patient has been dosed with AB-1015 in a Phase 1, first-in-human clinical trial for patients with ovarian cancer that is resistant to platinum-based regimens. It is our first internally discovered T cell medicine to enter clinical development: shorturl.at/iwT03
2
10
108
20,482
17 Oct 2022
Very interesting as usual, Rob.
1
10
5 Oct 2022
Go Deb go! Well deserved award to @DebattamaSen We’re going to learn a lot about the wiring of T cells from the Sen lab.
4 Oct 2022
Early-stage investigators proposed innovative high-impact research ideas for the @NIHDirector’s New Innovator Award. See the projects the awardees will pursue: bit.ly/hrhr2022nia #NIHHighRisk
ALT Collage of the 2022 NIH Director's New Innovator Awardees.
1
22
Nick Haining retweeted
29 Sep 2022
Our latest paper is out in @NatImmunol. This work represents a years-long effort from @dubrot_j Peter Du, @kathleenbyates @sarahkatelr and others to identify immune evasion genes using in vivo #CRISPRscreens in mouse cancer models treated with ICB. rdcu.be/cWcrJ
3
23
120
27 Sep 2022
Delighted for the opportunity to collaborate with the rockstar team at Genentech and deploy Arsenal's tech stack to solve the biggest challenges in T cell therapy. This is going to be a lot of fun.
27 Sep 2022
ArsenalBio will receive $70 million for a multi-year collaboration with Genentech to deploy ArsenalBio’s proprietary technology for high-throughput screening and engineering of T-cells to advance next-generation cell therapies for cancer. lnkd.in/ggcVFqqu #genentech
3
3
64
6 Sep 2022
Grateful for this opportunity to keep raising the bar for better engineered T cell therapies for patients with cancer. Can't wait to share what we're building. @ArsenalBio fiercebiotech.com/biotech/bm…
2
8
78
19 Aug 2022
This is my favorite tweet in quite some time.
19 Aug 2022
I have made a twitter account to tell you how disappointed I am with you for this tweet.
1
43
29 Jul 2022
Cogent analysis of decision-making around Covid boosters.
29 Jul 2022
What should you do about COVID vaccine boosters? Should you wait until the fall for a BA.4/5 version? How often can you get boosted? A few thoughts here: medpagetoday.com/opinion/sec…
1
5
28 Apr 2022
Having just spent 3 days at a #PICINetwork retreat, I think some of the most exciting and innovative work was presented by the scholars/early career scientists. The “kids” are alright.
1
24
Nick Haining retweeted
28 Jan 2022
Our CEO @KDrazan, MD, was featured in @_CellandGene this morning! Hear Ken’s take on ArsenalBio’s pioneering approach and role in the future of engineering CAR-T #celltherapies in the Q&A by @ErinHarris_1 here:
cellandgene.com/doc/computat… #EngineeredToCure
2
5
17 Jan 2022
Regardless about the generalizability of this finding I remain a firm proponent of snack-time.
17 Jan 2022
We tend to schedule our day ignoring that the times are not the same. For a judge, parole rulings were found to be dependent on the time of day: a prisoner had nearly a 0% chance of getting parole just before lunch, but 65% for parole right after lunch. pnas.org/content/108/17/6889
7